In summary, our data have demonstrated that activation of Slit2/Robo1 signaling is critically involved in the intestinal tumorigenesis and Slit2 may constitute a potential biomarker for the early detection and therapy of intestinal cancers. Here, SLIT2 is linked to intestinal cancer.